Search or
𝛼SK
𝛼SKbullish
Akeso (康方生物) Placement - Prepping for Commercialization
441 Views06 Jan 2021 10:28
Akeso Biopharma Inc (9926 HK) is looking to raise about US$154m from its primary placement to fund its expansion plans which includes building comm team, new production facility, and etc.
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »- Akeso (9926 HK) - OS Data Improved with Longer Follow-Up
- Akeso Inc (9926 HK): Pipeline Prospects Shine on Positive Trial Results; Placement Looks Attractive
- Akeso (9926 HK) - Key Data Readouts for AK112 to Validate Global Potential
- Akeso Biopharma (9926 HK) Placement - We Are Now at a Critical Point
- Akeso Inc Placement - Another Opportunistic Raise, Mixed past Deal but Is Relatively Small
Trending Collections
More »Trending Insights
More »- Sony Financial (8729 JP) Spinoff from Sony Group (6758 JP): Potential Index Flows
- HK Connect SOUTHBOUND Flows (To 19 Sep 2025); BIG Single Stock Trading Again, Feels Slightly Toppish
- The BOJ Announces the Start of ETF/JREIT Selldowns - Basically a Nothing-Burger
- Pre-IPO Zijin Gold (PHIP Updates) - Thoughts on the Business, the Forecast and Valuation Outlook
- Nvidia–OpenAI US$100bn Partnership: Asia Hardware Supply Chain Implications
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Akeso (康方生物) Placement - Prepping for Commercialization06 Jan 2021
- Akesobio (康方生物) IPO Trading: Action Post Near Zero Allocation23 Apr 2020
- Akesobio (康方生物) IPO: Expect near Zero Allocation14 Apr 2020
x